The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, Melanie Lukkes, Larissa Klaase, Thierry van den Bosch, Menno van Nimwegen, Sai Ping Lau, Kitty Latupeirissa, Sjoerd Schetters, Yvette van Kooyk, Louis Boon, Antien Moyaart, Yvonne M. Mueller, Peter D. Katsikis, Alexander M.M. Eggermont, Heleen Vroman, Ralph Stadhouders, Rudi W. Hendriks, Jan H. von der Thüsen, Dirk J. Grünhagen, Cornelis Verhoef, Thorbald van Hall, Joachim G.J.V. Aerts
Topics & Concepts
Immune checkpointBlockadePD-L1Cancer researchTumor microenvironmentLymphMelanomaT cellImmunityAdjuvantMedicineImmunotherapyImmunologyImmune systemTumor cellsPathologyInternal medicineReceptorCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research